저가주 코스닥 상장사들의 시가총액·주가 기준 상장폐지 우려
코스닥 상장사 신라섬유·엔젠바이오·앱튼·퀀텀레일이 주가 1000원 미달에 따른 상장폐지 또는 관리종목 지정 우려를 받고 있다.
Shareholder perspective 특정 상장사들의 상장 유지가 주가 기준으로 위태로워질 수 있어 투자자와 주주에게 직접적인 상장폐지 위험이 된다.
If shortfalls continue · After 19 trading days
27 / 90 trading days elapsed
Projected dates assume continued shortfalls without trading suspensions from the next trading day. Weekends and holidays are excluded, and thresholds apply by date.
Recovering stocks are also assumed to fall below the threshold at the next close. The projected date is not a final delisting decision date; confirm official status and schedules in KRX disclosures.
Use the period buttons above to adjust the range.
Separate · this company only
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||
| Revenue | 50.8 × 100M KRW | 30.3 × 100M KRW | 34.5 × 100M KRW | 38.2 × 100M KRW | 40 × 100M KRW | 47 × 100M KRW | 41.8 × 100M KRW | 41.8 × 100M KRW | 43.5 × 100M KRW | 44.3 × 100M KRW | 37.8 × 100M KRW | 36.7 × 100M KRW | 35.9 × 100M KRW |
| Operating profit | 7.3 × 100M KRW | 5.6 × 100M KRW | -25.6 × 100M KRW | 7.7 × 100M KRW | 5.4 × 100M KRW | 7.6 × 100M KRW | 7.3 × 100M KRW | 6.9 × 100M KRW | 6.7 × 100M KRW | 4.6 × 100M KRW | 3.9 × 100M KRW | 4.2 × 100M KRW | 4.9 × 100M KRW |
| Net income | 7.8 × 100M KRW | 4.8 × 100M KRW | -27.3 × 100M KRW | 2.6 × 100M KRW | 4.1 × 100M KRW | 1.7 × 100M KRW | 2.3 × 100M KRW | 3.5 × 100M KRW | 6.7 × 100M KRW | -3,584 × 10,000 KRW | -6.7 × 100M KRW | -3 × 100M KRW | 7,172 × 10,000 KRW |
| Operating margin | 14.34% | 18.38% | -74.22% | 20.12% | 13.45% | 16.11% | 17.51% | 16.41% | 15.37% | 10.49% | 10.37% | 11.36% | 13.59% |
| Balance sheet | |||||||||||||
| Total assets | 382.9 × 100M KRW | 371.1 × 100M KRW | 337 × 100M KRW | 325.2 × 100M KRW | 321.2 × 100M KRW | 318.6 × 100M KRW | 321.6 × 100M KRW | 323.9 × 100M KRW | 328.5 × 100M KRW | 319.4 × 100M KRW | 309.7 × 100M KRW | 306.3 × 100M KRW | 307.4 × 100M KRW |
| Total liabilities | 226 × 100M KRW | 212.8 × 100M KRW | 203.3 × 100M KRW | 188.5 × 100M KRW | 180.3 × 100M KRW | 176.1 × 100M KRW | 177.1 × 100M KRW | 175.8 × 100M KRW | 174.5 × 100M KRW | 165.4 × 100M KRW | 162.3 × 100M KRW | 162.4 × 100M KRW | 162.6 × 100M KRW |
| Total equity | 157 × 100M KRW | 158.3 × 100M KRW | 133.7 × 100M KRW | 136.7 × 100M KRW | 140.9 × 100M KRW | 142.5 × 100M KRW | 144.6 × 100M KRW | 148.1 × 100M KRW | 154 × 100M KRW | 153.9 × 100M KRW | 147.3 × 100M KRW | 144 × 100M KRW | 144.7 × 100M KRW |
| Cash flow statement | |||||||||||||
| Operating cash flow | - | - | - | - | - | - | - | - | - | - | - | 6.2 × 100M KRW | 7.2 × 100M KRW |
| Investing cash flow | - | - | - | - | - | - | - | - | - | - | - | -80 × 10,000 KRW | 1.3 × 100M KRW |
| Financing cash flow | - | - | - | - | - | - | - | - | - | - | - | -7.6 × 100M KRW | -6.4 × 100M KRW |
| Investment indicators | |||||||||||||
| ROE | 4.98% | 3.02% | -20.43% | 1.87% | 2.90% | 1.20% | 1.57% | 2.35% | 4.35% | -0.23% | -4.56% | -2.10% | 0.50% |
| Debt-to-equity ratio | 143.93% | 134.44% | 151.97% | 137.82% | 127.98% | 123.62% | 122.49% | 118.66% | 113.28% | 107.48% | 110.18% | 112.79% | 112.36% |
| Separate total assets | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - |
| PER | - | - | - | - | - | - | - | - | - | - | - | - | - |
| PBR | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Detailed accounts | |||||||||||||
| Current assets | - | - | 18 × 100M KRW | - | - | 10.9 × 100M KRW | - | - | 19.2 × 100M KRW | - | - | 5.1 × 100M KRW | 7.1 × 100M KRW |
| Non-current assets | - | - | 319.1 × 100M KRW | - | - | 307.6 × 100M KRW | - | - | 309.3 × 100M KRW | - | - | 301.2 × 100M KRW | 300.2 × 100M KRW |
| Current liabilities | - | - | 183.1 × 100M KRW | - | - | 145.3 × 100M KRW | - | - | 173.1 × 100M KRW | - | - | 162.3 × 100M KRW | 162.4 × 100M KRW |
| Non-current liabilities | - | - | 20.2 × 100M KRW | - | - | 30.8 × 100M KRW | - | - | 1.4 × 100M KRW | - | - | 1,235 × 10,000 KRW | 2,427 × 10,000 KRW |
| Share capital | - | - | 24.3 × 100M KRW | - | - | 24.3 × 100M KRW | - | - | 24.3 × 100M KRW | - | - | 24.3 × 100M KRW | 24.3 × 100M KRW |
| Capital surplus | - | - | - | - | - | - | - | - | - | - | - | 146.5 × 100M KRW | 146.5 × 100M KRW |
| Retained earnings | - | - | -36.7 × 100M KRW | - | - | -28.4 × 100M KRW | - | - | -16.8 × 100M KRW | - | - | -26.9 × 100M KRW | -26.1 × 100M KRW |
ROE is net income divided by closing equity. PER and PBR are omitted when the accounting scope or price date is unverified.
| Holder | Holding ratio | Change in ownership | Reason for filing | Filing date |
|---|---|---|---|---|
| 김대용 | 0.00% | -15.61% | 장내매매 | 2026-08-10 |
| 김대용 | 15.61% | -1.45% | 장내매매 | 2026-05-08 |
| 박재흥 | 61.03% | -0.74% | 특수관계인 주식 장내매도 | 2026-03-06 |
| 김대용 | 17.06% | +1.03% | 장내매매 | 2026-02-03 |
| 김대용 | 16.03% | +1.33% | 장내매매 | 2025-11-21 |
| 박재흥 | 61.77% | 0.00% | 상속주식에 대한 특수관계인 간 유류분 반환소송이 확정됨에 따른 소유주식 변동 | 2025-11-03 |
| 김대용 | 14.70% | +1.05% | 장내매매 | 2025-10-22 |
| 김대용 | 13.65% | +1.94% | 장내매매 | 2025-08-27 |
| 김대용 | 11.71% | +1.74% | 장내매매 | 2025-04-30 |
| 김대용 | 9.97% | +9.97% | 장내매매 | 2025-04-07 |
| Auditor | Type | Term start | Term end | Tenure | D-day |
|---|---|---|---|---|---|
| 김병수 | Audit committee member | - | 2026.03.13 | 5 years | Expired |
| 전용득 | Audit committee member | - | 2026.03.13 | 1 years | Expired |
| 이용문 | Audit committee member | - | 2027.03.15 | 5 years | D-130 |
| 김덕기 | Audit committee member | - | 2028.03.17 | 1 years | D-498 |
| 조상환 | Audit committee member | - | 2029.03.16 | 1 years | D-862 |
| Name | Position | Category | Age | Term end |
|---|---|---|---|---|
| 김덕기 | 독립이사 | 독립이사 | Age 71 | D-498 |
| 조상환 | 독립이사 | 독립이사 | Age 71 | D-862 |
| 이용문 | 상무이사 | Inside director | Age 60 | D-130 |
| 박재흥 | 대표이사 | Inside director | Age 59 | D-863 |
코스닥 상장사 신라섬유·엔젠바이오·앱튼·퀀텀레일이 주가 1000원 미달에 따른 상장폐지 또는 관리종목 지정 우려를 받고 있다.
Shareholder perspective 특정 상장사들의 상장 유지가 주가 기준으로 위태로워질 수 있어 투자자와 주주에게 직접적인 상장폐지 위험이 된다.